Summary It is not clear whether ankle fractures predict future osteoporotic fractures in women, and whether diabetes influences this relationship. We found that a prior ankle fracture does not predict subsequent osteoporotic fractures in women with or without diabetes. Introduction We aimed to determine: (1) whether a prior ankle fracture was a risk factor for a subsequent major osteoporotic fracture in older women; (2) whether this risk was modified by the presence of diabetes; (3) the risk factors for ankle fracture in older women. Methods We identified 3,054 women age 50 years and older with diabetes and 9,151 matched controls using the Manitoba Bone Density Program database. Multivariable regression models were used to examine factors associated with prior ankle fracture, and the importance of prior ankle fracture as a predictor of subsequent major osteoporotic fracture during a mean 4.8 years of observation. 
Introduction
Low-energy fragility fractures, or osteoporotic fractures, are often the first clinical sign of skeletal fragility [1] . Osteoporotic fractures have been defined as fractures of the hip, pelvis, spine, humerus, wrist, rib, clavicle, scapula, or sternum [2, 3] . Fractures of the hip and spine in particular are associated with severe disability, decreased health related quality of life, increased mortality and economic burden [4, 5] . Various risk factors have been identified that influence fracture risk including previous fracture, gender, body mass index (BMI), parental history of a hip fracture, smoking status, prolonged glucocorticoid exposure, rheumatoid arthritis, secondary causes of osteoporosis, and high alcohol intake [6, 7] . A previous osteoporotic fracture is considered to be one of the strongest risk factors for subsequent osteoporotic fracture, and this risk is largely independent of bone mineral density (BMD) [3] . Capturing osteoporotic fracture history provides valuable information for assessing future fracture risk and can be used with other key risk factors to initiate fracture prevention interventions [7, 8] .
Ankle fractures are one of the most common fracture types that occur in the adult population, however it is unclear if these fractures should be considered osteoporotic fractures, or if they predict future fragility fractures [1, 9, 10] . Ankle fractures tend to occur more frequently in younger, obese individuals who are frequent fallers, and the incidence does not increase with age, excluding ankle fractures from the osteoporotic fracture class [1, 11, 12] . Current evidence suggests that adults with type 2 diabetes may be at increased risk of experiencing ankle fractures, in addition to the more typical osteoporotic fractures, despite having higher BMD [13] [14] [15] . Whether the occurrence of an ankle fracture signifies an increased risk of future fracture is unclear.
The purpose of the current study was to determine whether a prior ankle fracture was a risk factor for a subsequent major osteoporotic fracture in older women, and whether this risk was modified by the presence of diabetes.
Methods

Design overview
A matched cohort study was carried out using the anonymized Population Health Information System (POPULIS) data repository at the Manitoba Centre for Health Policy (MCHP), University of Manitoba [16] . The population based data repository contains information regarding: patient demographics; date and type of service received; in-patient, out-patient, and office-based diagnoses and procedures performed; and prescription medications dispensed to out-patients. Medications are classified according to the Anatomic Therapeutic Chemical (ATC) of the WHO Collaboration Centre for Drugs Statistics Methodology. The accuracy and validity of the POPULIS databases has been previously published [17] . For this analysis we used repository data from April 1, 1987 to March 31, 2007 (pharmacy dispensation data were only available after April 1, 1995) .
The MHCP data repository is linked to the Manitoba Bone Density Program database through an anonymized (scrambled) personal health identification number. Details on the construction and validation of the Manitoba Bone Density Program database have been described elsewhere [18] . Briefly, the database contains all clinical BMD measurements for individuals tested in Manitoba since January 1, 1990 . In the province of Manitoba's publicly funded medical care system, BMD testing is provided for all women who are older than 65 years, or for younger women with a fragility fracture, who use systemic glucocorticoids for more than 3 months per year, have osteopenia diagnosed by X-ray, have experienced menopause prior to age 45 years, or who present with other risk factors for osteoporosis as determined by their referring physician.
Study population
This study used the Manitoba Bone Density Program database to identify women who (as of March 31, 2007) were over the age of 50 years at the time of BMD measurement, had a valid recorded height and weight, and had a BMD measurement recorded for the femoral neck (FN) site. For those who had more than one DXA assessment, the first BMD measurement was used for analysis. Diabetes was identified by the presence of either two separate physician claims for diabetes within 2 years, or a single hospitalization with a diagnosis of diabetes (International Classification of Diseases 9th revision Clinical Modification [ICD-9-CM] code 250). This method of identifying individuals with diabetes has been well validated [19] . Each diabetes subject was matched to three controls in the database without diabetes. Subjects with diabetes and controls were matched based on: BMD testing at the same facility; BMD testing performed within 12 months; and age within 2.5 years. The research ethics board for the University of Manitoba approved this study, and data access was granted by the Manitoba Health Information Privacy Committee.
Fracture ascertainment
Prior ankle fractures were identified according to the ICD-9-CM 824 code. This code includes medial malleolus, lateral malleolus, bimalleolar, and trimalleolar fractures. The proportion of individuals with prevalent fractures was calculated by dividing the number of fractures that occurred prior to the date of BMD testing by the number of individuals in each group. The following ICD-9-CM codes were used to identify major osteoporotic fractures: ICD-9-CM 820-821 with site specific fracture fixation code (hip); ICD-9-CM 813 with site specific fracture fixation or casting code (forearm); ICD-9-CM 805 (clinical spine); ICD-9-CM 812 (proximal humerus). Fracture definitions required the presence of two or more relevant hospital or physician ICD-9-CM fracture codes [20] . All fractures that were associated with trauma codes were excluded from the analysis. Incident fractures were identified as fractures that occurred between the date of BMD testing and March 31, 2007. To minimize the potential for counting health care interactions related to the same injury, fracture codes for the same site that occurred within 180 days were ignored.
Covariates
Femoral neck (FN) BMD measurements were assessed using either pencil-beam dual X-ray absorptiometry (DXA) (Lunar DPX; GE Lunar, Madison, WI, USA) if the measurement was taken before the year 2000, or fan-beam DXA (Lunar Prodigy; GE Lunar) after the year 2000. There were no clinically significant differences between the analyses using the different instruments (T-score differences <0.2). All systems showed constant long-term performance, and adequate in vivo system precision [21] . The DXA scans were analyzed by technicians according to the manufacturer's guidelines. The T-scores and Z-scores were calculated based on reference data for U.S. white females from the NHANES III survey [22] . Additional variables collected at the time of BMD measurement were weight and height (by self-report before year 2000, measured after year 2000). The provincial pharmacy database was used to identify use of osteoporosis-related medication (90 days or more of pharmacy dispensations for hormone therapy, bisphosphonate, selective estrogen receptor modulator, parathyroid hormone or recombinant human parathyroid hormone analog , calcitonin during the year prior to the BMD test). A global comorbidity score was constructed based upon the Johns Hopkins Case-Mix System [23] . Briefly, the number of ambulatory diagnostic groups (ADGs) is reflective of the number and severity of comorbid conditions. The number of ADGs was categorized as 0-2 (reference), 3-5, or 6 or more ADGs. Other covariates associated with skeletal fragility were defined from the POPULIS data repository: chronic obstructive pulmonary disease (a proxy for smoking, as smoking cannot be defined from administrative data) [24] , alcohol and substance abuse diagnosis, rheumatoid arthritis, hyperthyroidism, dementia, and prolonged glucocorticoid use (at least 90 days of pharmacy dispensations in the year before BMD testing at a mean daily dose of prednisone-equivalent 7.5 mg or greater) [25, 26] .
Statistical analysis
Baseline cohort characteristics as of the index date (time of BMD measurement) are presented as mean (SD) or frequencies. Differences in baseline characteristics between individuals with and without diabetes were evaluated using unpaired Student's t-tests (continuous variables) and chisquare tests (categorical variables). Multivariable logistic regression analysis was performed to model the relationship between prior ankle fracture and diabetes adjusted for: age, BMI, FN BMD, previous major osteoporotic fracture, number of ADGs, chronic obstructive pulmonary disease, alcohol and substance abuse diagnosis, rheumatoid arthritis, hyperthyroidism, dementia, prolonged glucocorticoid use and osteoporotic medication use [25] [26] [27] . A multivariable Cox proportional hazards regression model was used to determine the predictors of time to major osteoporotic fracture as a function of the same variables. In addition to survival models stratified for the presence/absence of diabetes, a combined model was constructed that included an interaction term for diabetes and prior ankle fracture. Odds ratios (OR) and hazard ratios (HR) were generated from the regression models with corresponding 95% confidence intervals (CI). All statistical analyses were performed using Statistica (Version 8.0, StatSoft, Inc., Tulsa, OK, USA). The criterion for statistical significance was set at a p value of 0.05.
Results
The characteristics of the 3054 women with a diagnosis of diabetes and 9151 women without a diagnosis of diabetes are shown in Table 1 . The cohorts were well matched for age: mean for women with diabetes 68.0±9.3 years, mean for controls without diabetes 67.9±9.2 years (p=0.773). On average, the women with diabetes had a greater BMI compared to the non-diabetic control cohort (29.9±6.3 versus 26.6±5.0 kg/m 2 , p<0.001). Women with diabetes had a greater number of ADGs than women without diabetes, and also higher average FN bone density Tscores and Z-scores (both p<0.001) ( Table 1) .
Despite having higher FN bone density measurements compared to controls, women with diabetes had experienced a greater number of prior ankle fractures (5.7% versus 4.2%, p<0.001) ( Table 1 ). In the overall study cohort, greater BMI, previous major osteoporotic fracture, and six or more ADGs were associated with a prior ankle fracture (Table 2 ). There was no relationship between a diagnosis of diabetes and prior ankle fracture after adjustment for other factors (OR 1.13; 95% CI, 0.93-1.38; p=0.200).
No difference was found in the number of incident ankle fractures during mean 4.8 years of follow-up: 17/3054 (0.6%) for women with diabetes versus 49/9151 (0.5%) for women without diabetes (p=0.892). A prior ankle fracture did not show a significant association with subsequent major osteoporotic fracture in women with diabetes (adjusted HR 1.13; 95% CI, 0.70-1.83; p=0.623) or in women without diabetes (adjusted HR 1.16; 95% CI, 0.79-1.71; p=0.460). When the two groups were combined, the relationship was also not significant (adjusted HR 1.17; 95% CI, 0.79-1.73; p=0.316) and there was no evidence an interaction between diabetes and ankle fracture (p=0.971) (Fig. 1) .
Discussion
In this large matched-cohort study, we found that a prior ankle fracture did not predict a subsequent major osteoporotic fracture in older women with or without diabetes. Elevated BMI, previous major osteoporotic fracture, and six or more ADGs were significant risk factors for ankle fracture.
The evidence on ankle fracture as a risk factor for a subsequent major osteoporotic fracture is limited, as smaller cohort and questionnaire-based studies have produced conflicting results. In a retrospective study, ankle fractures were associated with hip fractures in women 70 years of age or younger (OR 1.81; 95% CI, 1.02-3.19) and spine fractures in women 71 years of age or older (OR 1.49; 95% CI, 1.01-2.19) [28] . However, in a 4-year prospective cohort study of Fig. 1 Forest plot indicating the risk associated with a subsequent major osteoporotic fracture in women with a previous ankle fracture [30] . Our study provides additional evidence that prior ankle fractures in women over age 50 years, with or without diabetes, are not predictive of osteoporotic fractures, and as suggested by others, should not be considered an osteoporotic fracture [2] . We demonstrated that a prior major osteoporotic fracture, elevated BMI, and the presence of multiple comorbidities (6 or more ADGs) were significantly related to prior ankle fracture. These data complement the findings from a cohort study of perimenopausal women from Finland which revealed that elevated BMI, prior osteoporotic fracture, and three or more prescription drugs independently increased the risk of ankle fracture [31] . Though not assessed in this study, the duration of diabetes and type 2 diabetesrelated complications such as retinopathy may also contribute to ankle fracture risk, as these factors are known to influence the risk of other fractures in patients with diabetes [32] . The relationship between obesity and ankle fracture may be driven by the higher-weight-associated increase in energy transmitted through the ankle joint during a fall. Additional risk factors that have been associated with ankle fractures include a history of falls, vigorous physical activity, family history of hip fracture, and younger age [11, 31, 33, 34] . The pathology of ankle fracture is complex, and specific covariates like obesity, treatment with exogenous insulin, the presence of comorbid conditions, and having an osteoporotic fracture history appear to be more important contributors than BMD and the presence of diabetes alone.
There were several study limitations. We were unable to differentiate between diagnoses of type 1 and type 2 diabetes; however, it is likely that most of the cases had type 2 diabetes given the mean age of our cohort [35, 36] . We were unable to evaluate the use of insulin or other antihyperglycemic medications. Various reports have indicated that the use of thiazolidinediones is associated with an increased fracture risk [37] [38] [39] .
In conclusion, we found that prior ankle fracture was not a risk factor for subsequent major osteoporotic fracture in women with and without diabetes. Therefore, the presence of an ankle fracture alone does not indicate a need for further osteoporosis assessment in women greater than 50 years of age. Although having a diagnosis of diabetes does not appear to increase the risk of ankle fractures, other clinical risk factors that may be more prevalent in individuals with diabetes, such as obesity and multiple comorbidities, are associated with increased ankle fracture risk. Further study is warranted to confirm clinical risk factors for osteoporotic fracture risk that may be specific to individuals with diabetes.
